Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,223.71 Average PT from Analysts

Mettler-Toledo International Inc. (NYSE:MTDGet Free Report) has been assigned an average rating of “Hold” from the five research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $1,223.71.

A number of research firms recently commented on MTD. Citigroup reaffirmed a “sell” rating and set a $975.00 price objective (down previously from $1,050.00) on shares of Mettler-Toledo International in a research note on Monday, December 11th. StockNews.com cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, March 23rd.

Read Our Latest Research Report on Mettler-Toledo International

Insider Activity

In other Mettler-Toledo International news, insider Christian Magloth sold 400 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $1,278.73, for a total transaction of $511,492.00. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at $938,587.82. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, insider Christian Magloth sold 400 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $1,278.73, for a total value of $511,492.00. Following the transaction, the insider now owns 734 shares of the company’s stock, valued at approximately $938,587.82. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $1,210.83, for a total transaction of $363,249.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at approximately $5,950,018.62. The disclosure for this sale can be found here. Insiders sold a total of 951 shares of company stock valued at $1,170,256 in the last 90 days. 1.94% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds have recently modified their holdings of the stock. MV Capital Management Inc. raised its stake in shares of Mettler-Toledo International by 162.5% during the fourth quarter. MV Capital Management Inc. now owns 21 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 13 shares during the period. CVA Family Office LLC purchased a new stake in Mettler-Toledo International during the 4th quarter worth $27,000. Spartan Planning & Wealth Management purchased a new position in Mettler-Toledo International in the 4th quarter valued at about $27,000. Gladius Capital Management LP acquired a new stake in shares of Mettler-Toledo International during the third quarter valued at about $27,000. Finally, Bellevue Group AG purchased a new stake in shares of Mettler-Toledo International during the fourth quarter worth about $30,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,335.84 on Thursday. The firm’s 50-day moving average is $1,241.05 and its two-hundred day moving average is $1,150.67. The company has a market capitalization of $28.57 billion, a PE ratio of 37.22, a price-to-earnings-growth ratio of 3.60 and a beta of 1.15. Mettler-Toledo International has a 12-month low of $928.49 and a 12-month high of $1,615.97.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its earnings results on Friday, February 9th. The medical instruments supplier reported $9.40 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $10.32 by ($0.92). The company had revenue of $934.90 million during the quarter, compared to analysts’ expectations of $959.45 million. Mettler-Toledo International had a net margin of 20.82% and a negative return on equity of 904.59%. Mettler-Toledo International’s quarterly revenue was down 11.6% compared to the same quarter last year. During the same period in the previous year, the company posted $12.10 EPS. On average, analysts forecast that Mettler-Toledo International will post 39.9 EPS for the current fiscal year.

About Mettler-Toledo International

(Get Free Report

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.